PARP inhibition causes premature loss of cohesion in cancer cells

Eva Kukolj1, Tanja Kaufmann1, Amalie E Dick2

  • 1Max F. Perutz Laboratories, University of Vienna, Vienna Biocenter (VBC), Dr. Bohr-Gasse 9, Vienna, Austria.

Oncotarget
|December 22, 2017
PubMed

Insights

Poly(ADP-ribose) polymerases (PARPs) inhibition disrupts mitosis, causing sister chromatid scattering in cancer cells. This occurs when PARP inhibitors like olaparib engage PARP1/2 during S-phase, impairing replication and cohesion.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Therapeutics

Background:

  • Poly(ADP-ribose) polymerases (PARPs) are crucial for DNA repair and mitotic progression.
  • PARP inhibitors, such as olaparib, are used in cancer therapy, but their precise anti-tumor mechanisms, particularly concerning mitosis, require further elucidation.
  • Understanding PARP inhibitor effects on cell division is vital for optimizing cancer treatment strategies.

Purpose of the Study:

  • To investigate the impact of PARP inhibition on mitosis in various cancer and non-cancerous cell types.
  • To determine the role of PARP1 and PARP2 protein levels and catalytic activity in olaparib-induced mitotic defects.
  • To explore the relationship between replication stress and mitotic aberrations caused by PARP inhibition.

Main Methods:

  • Live-cell imaging was employed to observe mitotic progression in cancer and non-cancer cells treated with olaparib.
  • PARP1 and PARP2 gene expression levels were manipulated (depletion and overexpression) to assess their influence on observed phenotypes.
  • Cells were treated with olaparib during different cell cycle phases (S-phase vs. other phases) to pinpoint the timing of critical events.

Main Results:

  • Olaparib induced significant mitotic perturbations, including chromosome misalignment, anaphase delay, and sister chromatid scattering due to cohesion fatigue.
  • PARP1/2 depletion reversed these defects, while PARP2 overexpression exacerbated them, indicating that olaparib-bound PARP1/2, not just catalytic inactivity, drives the phenotype.
  • The sister chromatid scattering phenotype was prominent in cancer cells with high PARP1/2 levels and occurred specifically when olaparib was administered during S-phase, suggesting replication fork trapping.
  • Replication-perturbing agents like topoisomerase inhibitors and cisplatin mimicked these mitotic issues, highlighting a common pathway.

Conclusions:

  • PARP inhibition by olaparib causes mitotic errors, specifically sister chromatid scattering, by trapping PARP1/2 at replication forks during S-phase, thereby compromising sister chromatid cohesion.
  • The observed mitotic defects are dependent on the levels of PARP1 and PARP2 and are linked to replication stress, suggesting a broader implication for DNA-damaging chemotherapies.
  • These findings provide critical insights into the mode of action of PARP inhibitors and their impact on cancer cell division.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.2K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.2K
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.5K